H. M. Branderhorst et al. / Tetrahedron 63 (2007) 4290–4296
4295
trityl cation had ceased. The resin was washed with CH2Cl2
(6ꢁ) and Et2O (2ꢁ) and dried for 2 h. In a flask the resin
was combined with peracetylated galactopyranose (1.72 g,
4.40 mmol), CH2Cl2 (5 mL) was added followed by
BF3$Et2O (0.56 mL, 4.40 mmol). The reaction mixture
was stirred for 20 h. Then the resin was filtered off and
washed with CH2Cl2 (4ꢁ2 min) and Et2O (2ꢁ2 min). The
glycosylation procedure was repeated to guarantee a full
loading of the resin. The resin was subjected to the deacety-
lation procedure A. A 50-mg sample was benzoylated and
cleaved from the resin to indicate a loading of 0.8 mmol/g.
Finally procedure B was followed.
was washed with NMP (4ꢁ10 mL, 2 min each) and CH2Cl2
(4ꢁ10 mL, 2 min each). Kaiser test indicated the reaction to
be complete. To the resin was added a mixture of 12 (1.09 g,
1.56 mmol), HATU (593 mg, 1.556 mmol), and DIPEA
(515 mL, 3.12 mmol) in dry NMP (10 mL). The resin was
shaken for 20 h and the resin was filtered and washed with
NMP (4ꢁ10 mL, 2 min each), CH2Cl2 (4ꢁ10 mL, 2 min
each), and Et2O (2ꢁ10 mL, 2 min each). Standard Fmoc
analysis revealed a loading of 0.48 mmol/g. Although the
Kaiser test revealed a complete coupling, a capping reaction
(10 mL capping solution) was performed for 1 h. The Fmoc
group was cleaved by piperidine as described above. The
resin was swollen in dry pyridine (10 mL) and benzoyl chlo-
ride (0.91 mL, 7.8 mmol) was added. N2 was bubbled
through the mixture for 1 h followed by washing with
CH2Cl2 (6ꢁ10 mL, 2 min each) and Et2O (2ꢁ10 mL,
2 min each). Hydroxyl deprotection was performed accord-
ing to procedure A, selective protecting group chemistry was
performed according to procedure B.
4.6.4. Resin (11). Detritylation was performed as described
for the synthesis of resin 10. The 3-[4-(tritylmercapto)phe-
nyl]propionyl aminomethyl functionalized polystyrene resin
(0.44 mmol) was combined with donor 3,4,6-tri-O-acetyl-
2-O-benzyl-a/b-D-galactopyranosyl
trichloroacetimidate
(476 mg, 0.88 mmol, for synthesis see Supplementary data).
To this CH2Cl2 (15 mL) was added and the reaction mixture
was cooled to 0 ꢀC under an N2 atmosphere. After 30 min
TMSOTf (17 mL, 0.09 mmol) was added and the mixturewas
stirred slowly for 3 h. Then the mixture was warmed to rt and
stirred additionally for 20 h. The resin was transferred to a
solid-phase reaction vessel and washed with CH2Cl2 (4ꢁ)
and Et2O (2ꢁ). The glycosylation procedure was repeated
to guarantee a full loading of the resin. The resin was sub-
jected to the deacetylation procedure A. A 50-mg sample
was benzoylated and cleaved from the resin to indicate a
loading of 0.5 mmol/g. Finally procedure B was followed.
4.6.8. O-(2,3,4,6-Tetra-O-acetyl-b-D-galactopyranosyl)-
(1/6)-(2,3,4-tri-O-benzoyl-N-(carboxamido N-benzoyl-
L-glutam-5-oyl)-b-D-galactopyranosylamine) (15a). Gly-
cosylation of resin 13 with 7 according to procedure C, fol-
lowed by cleavage from the resin by procedure E yielded
15a (white solid) (16.4 mg, 25%): nmax (KBr)¼3500–3100
(br), 2924, 1734, 1262, 1070, and 711 cmꢂ1 1H NMR
.
(500 MHz, CDCl3): 8.10–7.23 (22H, m, Ph, NH2), 6.74
(1H, br t, C(O)NHC-1), 5.92 (1H, dd, H-4, J3,4¼3.0 Hz),
5.73 (1H, dd, H-3, J2,3¼10.0 Hz, J3,4¼3.5 Hz), 5.67 (1H, t,
H-2, J1,2¼9.0 Hz), 5.61 (1H, t, H-1, J1,2¼8.5 Hz), 5.36
(1H, s, NHBz), 5.32 (1H, d, H-40, J3,4¼3.0 Hz), 5.17 (1H,
4.6.5. Fluoro O-(2,3,4,6-tetra-O-acetyl-b-D-galactopyra-
nosyl)-(1/6)-2,3,4-tri-O-benzoyl-a/b-D-galactopyrano-
side (8). Either resin 6, or 10 or 11 (100–300 mg) was
glycosylated according to procedure C and the product
was cleaved from the resin according to procedure D, to
yield monosaccharide 9 (clear glass) and the disaccharide
8 (white foam). Compound 8 (a/b¼1/1): 1H NMR
(500 MHz, CDCl3): 8.08–7.27 (15H, m, Ph), 6.07 (0.5H,
d, H-1a, JH,F¼53 Hz), 5.98–5.84 (2H, m, H-2 and H-4),
5.70–5.58 (1H, 2ꢁm, H-3), 5.63 and 5.53 (0.5H, 2ꢁd,
H-1b, JH,F¼51.8 Hz, J1,2¼6.4 Hz), 5.36 (1H, s, H-40), 5.20
dd, H-20, J2 ,3 ¼10.5 Hz, J1 ,2 ¼8.0 Hz), 4.99 (1H, dd,
0
0
0
0
H-30, J2 ,3 ¼10.0 Hz, J3 ,4 ¼3.0 Hz), 4.58 (1H, d, H-1 ,
0
0
0
0
0
0
0
J1 ,2 ¼8.0 Hz), 4.65–4.61 (1H, m, CHa), 4.26 (1H, t, H-5,
J5,6¼6.0 Hz), 4.08–3.83 (4H, m, H-50, 2ꢁH-60 and 2ꢁH-6),
2.59–2.51 and 2.42–2.27 (2ꢁ1H, 2ꢁm, CH2g), 2.10–1.94
(2H, m, CH2b), 2.13, 2.06, 1.98, and 1.97 (4ꢁ3H, 4ꢁs,
C(O)CH3). 13C NMR (125.5 MHz, CDCl3): 170.7, 170.5,
170.3, and 169.3 (C(O)CH3), (C(O)NHC-1), 133.3–128.3
(Ph), 100.9 (C-10), 78.9 (C-1), 75.5 (C-5), 71.5 (C-3), 70.8
(C-2), 70.8 (C-30), 70.6 (C-50), 68.0 (C-4), 68.2 (C-20), 66.3
(H-60), 66.7 (C-40), 60.7 (H-6), 52.7 (Ca), 32.7 (CH2g),
21.4, 20.5, and 20.3 (C(O)CH3). HRMS for C53H55N3O20
(M, 1053,338) M+H found 1054.295, calcd 1054.347.
(1H, t, H-20, J2 ,3 ¼9.8 Hz), 5.02 (1H, d, H-30,
0
0
0
0
0
J2 ,3 ¼10.3 Hz), 4.58–4.52 (1H, m, H-1 ), 4.65 and 4.30
(1H, 2ꢁbr s, H-5), 4.09–3.83 (5H, m, H-50, 2ꢁH-6, and
2ꢁH-60), 2.15, 2.07, 2.01, and 1.99 (4ꢁ3H, 4ꢁs,
C(O)CH3). 13C NMR (75.0 MHz, CDCl3): 170.2, 170.1,
and 169.6 (C(O)CH3), 165.4, 165.2, and 165.1 (C(O)Ph),
133.8–128.3 (Ph), 101.5 (C-10), 73.4, 73.3, 70.7, 69.9,
69.6, 68.5, 67.6, 66.9, 66.8, and 61.1 (C-2, C-20, C-3, C-30,
C-4, C-40, C-5, C-50, C-6, and C-60), and 20.6 (C(O)CH3).
4.6.9. O-(2,3,4,6-Tetra-O-pivaloyl-b-D-galactopyranosyl)-
(1/6)-(2,3,4-tri-O-benzoyl-N-(carboxamido N-benzoyl-
L-glutam-5-oyl)-b-D-galactopyranosylamine) (15b). Gly-
cosylation of resin 13 with 14 according to procedure C,
followed by cleavage from the resin by procedure E yielded
15b (white solid) (21.8 mg, 30%): nmax (KBr)¼3500–2800
4.6.6. Fluoro 2,3,4,6 tetra-O-acetyl-b-D-galactopyrano-
side (9). Compound 9 (only b isomer): H NMR spectrum
(br), 1730, 1684, 1533, 1451, 1267, 1107, and 709 cmꢂ1
.
1
1H NMR (500 MHz, CDCl3): 8.10–7.22 (22H, m, Ph, NH2),
6.85 (1H, br t, (CO)NHC-1), 5.90 (1H, dd, H-4, J3,4¼3.5 Hz,
J4,5¼1.0 Hz), 5.72 (1H, dd, H-3, J2,3¼10.0 Hz, J3,4¼3.5 Hz),
5.67 (1H, dd, H-2, J1,2¼8.5 Hz, J2,3¼10.0 Hz), 5.64 (1H, s,
is consistent with Ref. 15: (300 MHz, CDCl3): 5.42 (1H, s,
H-4), 5.36–5.29 (1H, m, H-2), 5.25 (1H, dd, J1,2¼7.2 Hz,
JH,F¼49.2 Hz), 5.05 (1H, d, H-3, J¼4.5 Hz), 4.21 (2H, d,
2ꢁH-6, J¼3.9 Hz), 4.06 (1H, t, H-5, J¼3.6 Hz), 2.18,
2.11, 2.07, and 2.01 (4ꢁ3H, 4ꢁs, C(O)CH3).
NHBz), 5.61 (1H, t, H-1, J1,2¼8.5 Hz), 5.35 (1H, d, H-40,
0
0
0
0
0
0
0
J3 ,4 ¼3.5 Hz), 5.19 (1H, dd, H-2 , J1 ,2 ¼8.0 Hz, J2 ,3
¼
10.5 Hz), 5.09 (1H, dd, H-30, J2 ,3 ¼10.5 Hz, J3 ,4 ¼3.5 Hz),
0
0
0
0
4.62 (1H, d, H-10, J1 ,2 ¼8.0 Hz), 4.61 (1H, m, CHa), 4.26–
4.23 (1H, m, H-5), 4.01–3.89 (4H, m, H-50, H-6a, and
2ꢁH-60), 3.76 (1H, dd, H-6b, J¼7.0 Hz, J¼11.0 Hz),
0
0
4.6.7. Resin (13). Fmoc loaded Rink aminomethyl polysty-
rene resin (1.00 g, 0.78 mmol NHFmoc) was treated with
20% piperidine in NMP (3ꢁ10 mL, 15 min each). The resin